Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases

被引:93
作者
Huang, XJ [1 ]
Wiernik, PH [1 ]
Klein, RS [1 ]
Gallagher, RE [1 ]
机构
[1] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, Bronx, NY 10467 USA
关键词
arsenoxide; programmed cell death; acute promyelocytic leukemia; HL-60; NB4; caspase inhibitor; PARP; PKC;
D O I
10.1007/BF02787360
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The primary objective of this study was to determine whether caspases are involved in arsenic trioxide(ATO)-induced apoptosis of human myeloid leukemia cells. A secondary objective was to determine whether apoptosis induced by ATO compared with VP-16 is differentially affected by an activator of protein kinase C (PKC), phorbol 12-myristate 13-acetate (PMA), which has been reported to inhibit apoptosis induced by some chemotherapeutic agents. NB4 and HL60 cells were incubated with ATO in the presence and absence of the caspase protease inhibitors Z-VAD.fmk or Y-VAD.cho. Apoptosis was assessed by morphology, DNA laddering and flow cytometry, Poly (ADP-ribose) polymerase (PARP) cleavage was used as a marker for the activation of caspases. PARP cleavage occurred during ATO-induced apoptosis in both NB4 and HL60 cells. Z-VAD.fmk, a broad-spectrum inhibitor, could block ATO-induced apoptosis and PARP cleavage, whilst Y-VAD.cho, a selective inhibitor of caspase 1, had no such effect, PMA pre-incubation for up to 8 hours under conditions known to activate PKC had no effect on either ATO- or VP-16-induced apoptosis. We conclude that in cultured myeloid leukemia cells ATO-induced apoptosis is executed by caspases from the distal, PARP-cleaving part of the activation cascade and that PKC activation has no effect on apoptosis induced by either ATO or VP-16 in these cells.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 22 条
[1]   Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents [J].
Antoku, K ;
Liu, Z ;
Johnson, DE .
LEUKEMIA, 1997, 11 (10) :1665-1672
[2]  
CHEN CQ, 1998, BLOOD, V89, P3345
[3]  
Chen GQ, 1996, BLOOD, V88, P1052
[4]  
Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1
[5]   Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents [J].
Datta, R ;
Banach, D ;
Kojima, H ;
Talanian, RV ;
Alnemri, ES ;
Wong, WW ;
Kufe, DW .
BLOOD, 1996, 88 (06) :1936-1943
[6]   Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis [J].
Droin, N ;
Dubrez, L ;
Eymin, B ;
Renvoizé, C ;
Bréard, J ;
Dimanche-Boitrel, MT ;
Solary, E .
ONCOGENE, 1998, 16 (22) :2885-2894
[7]   INVOLVEMENT OF AN ICE-LIKE PROTEASE IN FAS-MEDIATED APOPTOSIS [J].
ENARI, M ;
HUG, H ;
NAGATA, S .
NATURE, 1995, 375 (6526) :78-81
[8]   INDUCTION OF APOPTOSIS IN CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS AND ITS PREVENTION BY PHORBOL ESTER [J].
FORBES, IJ ;
ZALEWSKI, PD ;
GIANNAKIS, C ;
COWLED, PA .
EXPERIMENTAL CELL RESEARCH, 1992, 198 (02) :367-372
[9]  
Grant S, 1996, CLIN CANCER RES, V2, P1915
[10]  
Huang X. J., 1997, Blood, V90, p329A